Collaboration

Vantage News

Vantage's Stuart Kliman recently appeared on an episode of Biotalk, a Locust Walk Podcast series, where he discussed ways of optimizing alliance management, maximizing long-term deal value creation for life science companies, and the differences between deal-minded and implementation-minded negotiation approaches.
Read More »
Alliance Callout

Alliances

By working with Vantage, companies can maximize the performance of individual alliances, put under-performing alliances back on track, and ensure coordination and optimization of their entire alliance portfolio.
Read More »
SSM Call Out

Sourcing & Supply Chain Management

We specialize in procurement and supply chain transformation, category strategy development, SRM program implementation, negotiation advice, and training for procurement leaders and professionals.
Read More »
Sales Advisory

Sales and Account Management

We help sales organizations develop and implement innovative methods for negotiating and collaborating with customers.
Read More »
Slide 1

Enterprise Learning

We work with organizations to create and deliver highly interactive, experiential learning strategies that translate into real, measurable business results and are aimed at developing employees’ abilities in the most fundamental and critical areas of business relationship management.
Read More »

Vantage in HBR

Loading...

Vantage in Harvard Business Review

HBR Guide to NegotiatingHBR Guide to Negotiating now in Paperback by Jeff Weiss.


HBR Video:  Jeff Weiss Offers Tips and Advice on Negotiating


 

Sales study imageVantage's Pricing Study highlighted in HBR's January 2015 Issue

 

Recent Publications

  • Better Skills, Better Partnering

    8/1/17

    Although the pharmaceutical industry has been quick to embrace the value of partnerships and the subsequent improved access to new business opportunities, initially many companies did not fully understand what it really takes to be successful at alliance partnering. In the past five years, as partnering has become the new normal, Bayer and many other biopharma companies have sought to remedy this by building their corporate partnering capability. As this continues, all pharmaceutical companies will benefit from operating in an industry that is increasingly capable at partnering.

  • Biotalk Podcast with Stuart Kilman and Josh Hamermesh

    7/17/17

    Stuart Kliman recently appeared with Josh Hamermesh, Vice President at Locust Walk, on an episode of Biotalk, a Locust Walk Podcast series. They discussed ways of optimizing alliance management, maximizing long-term deal value creation for life science companies, and the differences between deal-minded and implementation-minded negotiation approaches.

  • Alliance Management Required: The Unique Alliance Management Needs of Pharma Option Deals

    1/26/17

    As pharmaceutical and mid-sized biotech companies increasingly seek to enhance their pipelines through externalized relationships, the option deal—typically with a smaller biotech—has become an increasingly popular contract structure.

View All Articles »